Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

ConclusionIn conclusion, second HCT is a viable option for disease relapse after TCD HCT for patients entering second HCT in remission and/or remission duration>  12 months after first HCT with acceptable rates of GVHD and donor engraftment.
Source: Experimental Hematology and Oncology - Category: Cancer & Oncology Source Type: research